Harvard Law School on Wednesday announced the launch of a first-of-its-kind psychedelics policy center that it hopes will inform legislation and help clinicians navigate this burgeoning medical space as reform continues to advance.
The Project on Psychedelics Law and Regulation (POPLAR) will be a three-year effort designed to “promote safety, innovation and equity in psychedelics research, commerce and therapeutics,” according to a press release.
In the announcement, Harvard’s Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics recognized that state and local psychedelics developments necessitate an evaluation of the policy impacts as well as the potential influence of private companies that seek to enter the market.
The project is “positioned to be a global leader for research and education in this space,” it said.
“Right now, there are a handful of psychedelics research centers at...
- read the rest of the article here